Back to Journals » Journal of Asthma and Allergy » New Promising Treatments for Type 2 and Non-Type 2 Asthma
SJR OA
CiteScore
Impact Factor
Journal of Asthma and Allergy
ISSN: 1178-6965
- View all (1102)
- Volume 19, 2026 (103)
- Volume 18, 2025 (148)
- Volume 17, 2024 (117)
- Volume 16, 2023 (125)
- Volume 15, 2022 (151)
- Volume 14, 2021 (149)
- Volume 13, 2020 (77)
- Volume 12, 2019 (37)
- Volume 11, 2018 (31)
- Volume 10, 2017 (36)
- Volume 9, 2016 (25)
- Volume 8, 2015 (14)
- Volume 7, 2014 (14)
- Volume 6, 2013 (16)
- Volume 5, 2012 (10)
- Volume 4, 2011 (11)
- Volume 3, 2010 (20)
- Volume 2, 2009 (12)
- Volume 1, 2008 (6)
Journal Articles:
- Targeted Personalized Biologic Therapies: Changing the Game in Asthma Treatment (2)
- Recurrent Pulmonary Infections: Diagnosis, Treatment, and Pathophysiology (1)
- Atopic Dermatitis and Other Atopic Comorbidities (5)
- Wheezing in Preschool Children: From Origins to Outcomes (1)
- From Guts to Lungs: Understanding Microbiome Dynamics in Respiratory Health (1)
- Artificial Intelligence and Machine Learning to Aid the Management of Allergic Respiratory Diseases (1)
- Anaphylaxis: Diagnosis and Treatment (5)
New Promising Treatments for Type 2 and Non-Type 2 Asthma
Although the hallmark of asthma pathobiology is airway inflammation, asthma is highly heterogeneous and is thus characterized by a variety of distinct symptoms supported by elaborate endotype networks of cellular and molecular systems. The goal of this Article Collection is to summarize recent developments pertaining to the inflammatory pathways underlying the phenotypes and endotypes of asthma. Clarifying the cellular and molecular targets of pharmacological therapies for this pervasive illness depends on ongoing work in this area.